Spectrum of benign lesions mimicking a malignant stricture at the liver hilum

Reviews on Recent Clinical Trials

Volumn 4, Issue 3, 2009, Pages 185-194

  Kassahun, Woubet Tefera ^a   Jonas, Sven ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Benign lesions; Biliary stricture; Hilar cholangiocarcinoma

Indexed keywords

CA 19-9 ANTIGEN; FLOXURIDINE; FLUOROURACIL; TUMOR MARKER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOMA; ASPIRATION BIOPSY; AUTOIMMUNE SCLEROSING PANCREATOCHOLANGITIS; BENIGN TUMOR; BILE DUCT CARCINOMA; BILE DUCT DISEASE; BILE DUCT OBSTRUCTION; CHOLANGITIS; CHOLECYSTITIS; CHRONIC PANCREATITIS; CLINICAL FEATURE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; HUMAN; INCIDENCE; INFLAMMATORY DISEASE; LIVER METASTASIS; LIVER RESECTION; LIVER TOXICITY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MIRIZZI SYNDROME; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PORTAL HYPERTENSION; POSITRON EMISSION TOMOGRAPHY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PSEUDOTUMOR; REVIEW; SARCOIDOSIS; SCLEROSING CHOLANGITIS;

BILE DUCT NEOPLASMS; BILIARY TRACT DISEASES; BIOLOGICAL MARKERS; BIOPSY; CHOLANGIOCARCINOMA; CONSTRICTION, PATHOLOGIC; DECOMPRESSION, SURGICAL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HUMANS;

EID: 73349122940     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488709789957547     Document Type: Review

References (149)

1. Hadjis NS, Collier NA, Blumgart LH, et al. Malignant masquerade at the hilum of the liver. Br J Surg 1985; 72: 659-61.
2. Standfield NJ, Salsbury JR, Howard ER. Benign non-traumatic inflammatory strictures of the extrahepatic biliary system. Br J Surg 1989; 76: 849-52.
3. Wetter LA, Ring EJ, Pellegrini CA, Way LW. Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors). Am J Surg 1991; 161: 57-63. [4] Verbeek PCM, van Leeuwen DJ, de Wit LT, et al. Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors. Surgery 1992; 112: 866-71.
4. Nakayama A, Imamura H, Shimada R, Miyagawa S, Makuuchi M, Kawasaki S. Proximal bile duct stricture disguised as malignant neoplasm. Surgery 1999; 125: 514-25.
5. Gerhards MF, Vos P, van Gulik TM, Rauws EA, Bosma A, Gouma DJ. Incidence of benign lesions in patients resected to suspicious hilar obstruction. Br J Surg 2001; 88: 48-51.
6. Principe A, Ercolani G, Bassi F, et al. Diagnostic dilemmas in biliary strictures mimicking cholangiocarcinoma. Hepato-Gastroenterology 2003; 50:1246-9.
7. Knoefel WT, Prenzel KL, Peiper M, et al. Klatskint tumors and Klatskin mimicking lesions of the biliary tree. Eur J Surg Oncol 2003; 29:658-61.
8. Koea J, Holden A, Chau K, McCall J. Differential diagnosis of stenosing lesions at the hepatic hilus. Worl J Surg 2004; 28: 466-70.
9. Park MS, Kim TK, Kim KW, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004; 233: 234-40.
10. Corvera CU, Blumgart LH, Darvishian H, et al. KClinical and pathologic features of proximal biliary strictures masquerading as hilar cholangiocarcinoma. J Am Coll Surg 2005; 201: 862-9.
11. Uhlmann D, Wiedmann M, Schmidt F, et al. Management and outcome in patients with Klatskin-Mimicking lesions of the biliary tree. J Gastrointest Surg 2006; 10: 1144-50.
12. Are C, Gonen M, DÁngelica M, et al. Differential diagnosis of proximal biliary obstruction. Surgery 2006; 140: 756-63.
13. Saluja SS, Sharma R, Paul S, Sahni P, Chattopadhyay TK. Differentiation between benign and malignant hilar obstructions using laboratory and radiological investigations: a prospective study. HPB 2007; 9: 373-82.
14. Kloek JJ, van Delden OM, Erdogan D, et al. Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J Gastroenterol 2008; 14: 5032-8.
15. Erdogan D, Kloek JJ, ten Kate FJW, et al. Immunoglobulin G4-related sclerosing cholangitis in patients resected for presumed malignant bile duct strictures. Br J Surg 2008; 95: 727-34.
16. te Boekhorst DS, Gerhards MF, van Gulik TM, Gouma DJ. Granular cell tumor at the hepatic duct confluence mimicking Klatskin tumor. Dig Surg 2000; 17: 299-303.
17. Ohsawa M, Aosaza K, Horiuchi K, et al. Malignant lymphoma of the liver: report of 5 cases and review of the litrature. Dig Dis Sci 1992; 37: 1105-09.
18. Eliason SC, Grosso LE. Primary biliary malignant lymphoma clinically mimicking cholangiocarcinoma: a case report and review of the literature. Ann Diagn Pathol 2001; 5: 25-33.
19. Binkley CE, Eckhauser FE, Colleti LM. Unusual cases of benign biliary strictures with cholangiographic features of cholangiocarcinoma. J Gastrointest Surg 2002; 6: 676-81.
20. Harell GS, Anderson MF, Berry PF. Cytologic bile examination in the diagnosis of biliary duct neoplastic strictures. AJR Am J Roenrgerol 1981; 137: 1123-6.
21. Evander A, Ihse I, Lunderquist A, et al. Percutaneous cytodiagnosis of carcinoma of the pancreas and bile duct. Ann Surg 1978; 188: 90-2.
22. Cohan RH, Illscas FF, Newman GE, et al. Biliary cytodiagnosis. Bile sampling for cytology. Invest Radiol 1985; 20: 177-9.
23. Ponchon T, Gagnon P, Berger F, et al. Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study. Gastrointest Endosc 1995; 42: 565-72.
24. van Gulik TM, Reeders JW, Bosma A, et al. incidence and clinical findings of benign inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc 1997; 46: 417-23.
25. Andersson R, Andren-Sandberg A, Lundstedt C, Tranberg KG. Implantation metastasis from gastrointestinal cancer after percutaneous puncture or biliary drainage. Eur J Surg 1996; 162: 551-4.
26. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38: 241-56.
27. Longmire WP, Jr, McArthur MS. The management of extrahepatic bile duct carcinoma. Jpn J Surg 1973; 3: 1-8.
28. Cameron JL, Broe P, Zuidema GD. Proximal bile duct tumors: surgical management with silastic transhepatic biliary stents. Ann Surg 1982; 196: 412-9.
29. Chapman RWG, Arborgh BAM, Rohdes JM, et al. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut 1980; 21: 870-7.
30. Thompson HH, Pitt HA, Tompkins RK, Longmire WP, Jr. Primary sclerosing cholangitis: a heterogeneous disease. Ann Surg 1982; 196: 127-36.
31. Broome U, Olsson R, Loof L, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610-5.
32. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004; 24: 115-25.
33. LaRussso NF, Shneider BL, Black D, et al. Primary sclerosing cholangitis: Summary of a workshop. Hepatology 2006; 44: 746-64.
34. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 2004; 99: 523-6.
35. Pitt HA, Dooley WC, Yeo CJ, Cameron JL. Malignancies of the biliary tree. Curr Prob Surg 1995; 32: 1-90.
36. Bergquist A, Glaumann H, Persson B, Broome U. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study. Hepatology 1998; 27: 311-6.
37. Abdalian R, Heathcote EJ. Sclerosing cholnagitis: a focus on secondary causes. Hepatology 2006; 44: 1063-74.
38. Buc E, Lesurtel M, Belghiti J. Is preoperative histological diagnosis necessary before referral to major surgery for cholangiocarcinoma? HPB 2008; 10: 98-105.
39. Sasahira N, Kawabe T, Nakamura A, et al. Inflammatory Pseudotumor of the liver and peripheral eosinophilia in autoimmune pancreatitis. World J Gastroenterol 2005; 11: 922-5.
40. Coffin CM, Hamphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol 1998; 15: 85-101.
41. Nonomura A, Minato H, Shimizu K, Kadoya M, Matsui O. Hepatic hilar inflammatory pseudotumor mimicking cholangiocarcinoma with cholangitis and phlebitis: a variant of primary sclerosing cholangitis? Pathol Res Pract 1997; 193: 519-25.
42. Amankonah TD, Strom CB, Vierling JM, Petrovic LM. Inflammatory pseudotumor of the liver as the first manifestation of Chrohn's disease. Am J Gastroenterol 2001; 96: 2520-2.
43. Horiuchi R, Uchida T, Kojima T, Shikata T. Inflammatory pseudotumor of the liver. Clinicopathological study and review of the literature. Cancer 1990; 65: 1583-90.
44. Menias CO, Surabhi VR, Prasad SR, Wang HL, Nara VR, Chintapalli KN. Mimics of cholangiocarcinoma: spectrum of disease. Radiographics 2008; 28: 1115-29.
45. Pack GT, Baker HW. Total right hepatic lobectomy: reports of a case. Ann Surg 1953; 138: 253-8.
46. Yan FH, Zhou KR, Jiang YP, Shi WB. Inflammatory pseudotumor of the liver: 13 cases of MRI findings. World J Gastroenterol 2001; 7: 422-4.
47. Tublin ME, Moser AJ, Marsh JW, Gamblin TC. Biliary inflammatory pseudotumor: imaging features in seven patients. Am J Roentgenol 2007; 188: W44-8.
48. Zen Y, Harada K, Sasaki M, et al. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Am J Surg Pathol 2004; 28: 1193-203.
49. Nakayma F, Solowa RD, Nakama T, et al. Hepatolithiasis in East Asia. Retrospective study. Dig Dis Sci 1986; 31: 21-6.
50. Harris HW, Kumwenda ZL, Sheen-Chen S. Recurrent pyogenic cholangitis. Am J Surg 1998; 176: 34-7.
51. Seel DJ, Park YK. Oriental inflectional cholangitis. Am J Surg 1983; 146: 366-70.
52. Lim JH. Oriental cholagiohepatitis: pathologic, clinical, and radiologic features. Am J Roentgenol 1991; 157: 1-8.
53. Sperling Rm, Koch J, Sandhu JS, Cello JP. Recurrent pyogenic cholangitis in Asian immigrants to the United States: natural history and role of therapeutic ERCP. Dig Dis Sci 1997; 42: 865-71.
54. Reynolds WR, Brinkman JD, Haney BD, Fticsar JE. Oriental Cholangiohepatitis. Mil Med 1994; 159: 158-60.
55. Park MS, Yu JS, Kim KW, et al. Recurrent pyogenic cholangitis: comparison between MR cholangiography and direct cholangiography. Radiology 2001; 220: 677-82.
56. Kim MJ, Cha SW, Mitchel DJ, Chung JJ, Park S, Chung JB. MR imaging findings in recurrent pyogenic cholangitis. AJR Am J Roentgenol 1999; 173: 1545-9.
57. Lim JH, Ko YT, Lee DH, Hong KS. Oriental cholangiohepatitis: sonographic findings in 48 cases. Am J Roentgenol 1990; 155: 511-4.
58. Chan FL, Man SW, Leong LL, Fan ST. Evaluation of recurrent pyogenic cholangitis with CT: analysis of 50 patients. Radiology 1989; 170: 165-9.
59. Coppel MS. Hepatobiliary manifestations of the acquired immune deficiency syndrome. Am J Gastroenterol 1991; 86:1-15.
60. Cello JP. Human immunodeficiency virus associated biliary tract disease. Semin Liver Dis 1992; 12: 213-28.
61. Margulis SJ, Honig CL, Soave R, Govoni AF, Mouradian JA, Jacobson IM. Biliary tract obstruction in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 207-10.
62. Bouche H, Housset C, Dumont JL. AIDS-related cholangitis: diagnostic features and course in 15 patients. J Hepatol 1993; 17: 34-9.
63. Dolmatch BL, Laing FC, Ferderle MP, Jeffery RB, Cello J. AIDS-related cholangitis: radiographic findings in 9 patients. Radiology 1987; 163: 313-6.
64. Cello JP, Chan MF. Long-term follow up of endoscopic retrograde cholangiopancreatography sphincterotomy for patients with acquired immune deficiency syndrome papillary stenosis. Am J Med 1995; 99: 600-03.
65. Nash JA, Cohen SA. Gallbladder and biliary tract disease in AIDS. Gastroenterol Clin North Am 1997; 26: 323-35.
66. Pol S, Romana CA, Richard S, et al. Microsporadia infection in patients with the human immunodeficiency virus and unexplained cholangitis. N Engl J Med 1993; 328: 95-9.
67. Finkelberg DL, Sahani D, Deshpande V, Brugge WR. Autoimmune pancreatitis. N Engl J Med 2006; 355: 2670-6.
68. Krasinskas AM, Raina A, Khalid A, Tublin M, Yadav D. Autoimmune pancreatitis. Gastroenterol Clin North Am 2007; 36: 239-57.
69. Ectors N, Maillet B, Aerts R, et al. Non-alcoholic duct destructive chronic pancreatitis. Gut 1997; 41: 263-8.
70. Kim KP, Kim MH, Song MH, Lee SS, Seo DW, Lee SK. Autoimmune chronic pancreatitis. Am J Gastroenterol 2004; 99: 1605-16.
71. Pearson RK, Longnecker DS, Chari ST, et al. Controversy in clinical pancreatology: autoimmunepancreatitis: does it exist? Pancreas 2003; 27: 1-13.
72. Kamisawa T, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Kamata N. Clinical difficulties in the differentiation of autoimmune pancreatitis and pancreatic carcinoma. Am J Gastroenterol 2003; 98: 2694-9.
73. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopatholigical entity of IgG4-related autoimmune disease. J Gastroenterol 2003; 38: 982-4.
74. Sarin SK, Bhatia B, Makawane U. Portal biliopathy in extrahepatic portal vein Obstruction. Ind J Gastroenterol 1992; 2: A82.
75. Sarin SK, Agarwal SR. Extrahepatic portal vein obstruction. Semin Liver Dis 2002; 22: 43-58.
76. Dumortier J, Vaillant E, Boillot O, et al. Diagnosis and treatment of biliary obstruction caused by portal cavernoma. Endoscopy 2003; 35: 446-50.
77. Condat B, Vilgrian V, Asselah T, et al. Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study. Hepatology 2003; 37: 1302-08.
78. Shin SM, Kim S, Lee JW, et al. Biliary abnormalities associated with portal biliopathy: evaluation on MR cholangiography. Am J Roentgenol 2007; 188: W341-7.
79. Bayrakatar Y, Balkanci F, Kayhan B, Ozenc A, Arslan S, Telatar H. Bile duct varices or "pseudocholangiocarcinoma sign" in portal hypertension due to cavernous transformation of the portal vein. Am J Gastroenterol 1992; 87: 1801-06.
80. Mirizzi PL. Sindrome del conducto hepatico. J Int Chir 1948; 8: 731-7.
81. Csendes A, Diaz JC, Burdiles P, Maluenda F, Nava O. Mirizzi syndrome and cholecystobiliary fistula: a unifying classification. Br J Surg 1989; 76: 1139-43.
82. Johnson LW, Sehon JK, Lee WC, Zibari GB, McDonald JC. Mirizzi's syndrome: experience from a multi-institutional review. Am Surg 2001; 67: 11-4.
83. Lai ECH, Lau WY. Mirizzi syndrome: history, present and future development. ANZ J Surg 2006; 76: 251-7.
84. Baer HU, Matthews JB, Schweizer WP, Gertsch P, Blumgart LH. Management of the Mirizzi syndrome and the surgical implication of cholecystocholedochal fistula. Br J Surg 1990; 77: 743-5.
85. Becker CD, Hassler H, Terrier F. Preoperative diagnosis of the Mirizzi syndrome: limitations of sonography and computed tomography. AJR Am J Roentgenol 1984; 143: 591-6.
86. Kunisaki SM, Hertl M, Bodner BE, Cosimi AB. Mirizzi syndrome secondary to an adenoma of the cystic duct. J Hepatobiliary Pancreat Surg 2005; 12: 159-62.
87. Loh A, Kamar S, Dickson GH. Solitary benign papilloma (papillary adenoma) of the cystic duct: a rare cause of biliary colic. Br J Clin Pract 1994; 48: 167-8.
88. Satoh H, Hirano T, Ogawa Y, et al. Adenoma arising from the cystic duct and extending to the confluence of the extrahepatic biliary tract. J Hepatbiliary Pancreat Surg 1999; 6: 186-9.
89. Allaire GS, Rabin L, Ishak KG, Sesterhenn IA. Bile duct adenoma. A study of 152 cases. Am J Surg Pathol 1988; 12: 708-15.
90. Kawakatsu M, Vilgrain V, Zins M, Vullierme M, Belghiti J, Menu Y. Radiologic features of papillary adenoma and papilomatosis of the biliary tract. Abdom Imaging 1997; 22: 87-90.
91. Buckley JG, Salimi Z. Villous adenoma of the common bile duct. Abdom Imaging 1993; 18: 245-6.
92. Jennings PE, Rode J, Coral A, Dowsett J, Lees WR. Villous adenoma of the common hepatic duct: the role of ultrasound in management. Gut 1990; 31: 558-60.
93. Burhans R, Meyers RT. Benign neoplasms of the extrahepatic biliary ducts. Am Surg 1971; 37: 161-6.
94. Cox CE, Davis-Allen A, Judson MA. Sarcoidosis. Med Clin North Am 2005; 89: 817-28.
95. Judson MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med 2007; 28: 83-101.
96. Pungpapong S, Steers JL, Wallace MB, Krishna M, Keaveny AP. Hepatobiliary sarcoidosis mimicking Klatskin's cholangiocarcinoma. Gastrointest Endosc 2006; 64: 124-5.
97. Ishak KG. Sarcoidosis of the liver and bile ducts. Myo Clin Proc 1998; 73: 467-72
98. Alam I, Levenson SD, Ferrell LD, Bass NM. Diffuse intrahepatic biliary strictures in sarcoidosis resembling sclerosing cholangitis. Case report and review of the litrature. Dig Dis Sci 1997; 42: 1295-1301.
99. Howard TJ, Bennion RS, Thompson JE Jr. Xanthogranulomatous cholecystitis: a chronic inflammatory pseudotumor of the gallbladder. Am Surg 1991; 57: 821-4.
100. Kwon AH, Matsui Y, Uemura Y. Surgical procedures and histopathologic findings for patients with xanthogranulomatous cholecystitis. J Am Coll Surg 2004; 199: 204-10.
101. Dixit VK, Prakash A, Gupta A, et al. Xanthogranulomatous cholecystits. Dig Dis Sci 1998; 43: 940-2.
102. Benbow EW. Xanthogranulomatous cholecystitis. Br J Surg 1990; 77: 255-6.
103. Shuto R, Kiyosue H, Komatsu E, Matsumoto S, Kawano K, Kondo Y, Yokoyama S, Mori H. CT and MR imaging findings of Xanthogranulomatous cholecystitis: correlation with pathologic findings. Eur Radiol 2004; 14: 440-6.
104. Kawate S, Ohawada S, Ikota H, Hamada K, Kashiwabara K, Morishita Y. Xanthogranulomatous cholangitis causing obstructive jaundice: a case report. World J Gastroenterol 2006; 12: 4428-30.
105. Krishna RP, Kumar A, Singh RK, Sikora S, Saxena R, Kapoor VK. Xanthogranulomatous inflammatory strictures of extrahepatic biliary tract: presentation and surgical management. J Gastroentest Surg 2008; 12: 836-41.
106. Batts KP. Ischemic cholangitis. Mayo Clin Proc 1998; 73:380-5.
107. Alazmi WM, McHenry L, Watkins JL, et al. Chemotherapy-induced sclerosing cholangitis: long-term response to endoscopic therapy. J Clin Gastroenterol 2006; 40: 353-7.
108. Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastroentest Cancer 2001; 30: 147-60.
109. Lorenz M, Muller HH. Randomized multicenter trail of fluorouracil plus leucoverin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with non-resectable liver metastases from colorectal carcinoma. J Clin Oncol 2000; 18: 243-54.
110. Martin RC, Edwards MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 2004; 188: 714-21.
111. Kerr DJ, McArdle SC, Ledermann J, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicenter randomized trail. Lancet 2003; 361: 368-73. [113] Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-48.
112. Hohn D, Melnick J, Stagg R, et al. Biliary sclerosis in patients receiving hepatic arterial infusion of floxuridine. J Clin Oncol 1985; 3: 98-102.
113. Jarnagin WR, Winston C. Hilar cholagiocarcinoma: diagnosis and staging. HPB 2005; 7: 244-51.
114. Pellegrini CA, Thomas MJ, Way LW. Bilirubin and alkaline phosphatase values before and after surgery for biliary obstruction. Am J Surg 1982; 143: 67-73.
115. Khan SA, Thomas HC, Davidson BR, Tailor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-14. [118] Jarnagin WR, Fong Y, DeMeteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234: 507-19. [119] Nehls O, Gregor M, Klump B. Serum and bile markers for cholangiocarcinoma. Semin Liver Dis 2004; 24: 139-54.
116. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA19-9 in the diagnosis of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95: 204-07.
117. Albert MB, Steinberg WM, Henry JP. Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig Dis Sci 1988; 33: 1223-5.
118. Lamerz R. Roll of tumor markers, cytogenetics. Ann Oncol 1999; 10(Suppl 4): 145-9.
119. Larusso NF. Proteins in bile: how they get there and what they do. Am J Physiol 1984; 247: G199-205
120. Osnes M, Serck-Hansenn A, Myren J. Endoscopic ratrograde brush cytology (ERBC) of the biliary and pancreatic ducts. Scand J Gastroenterol 1975; 10: 829-31.
121. Vandervoort J, Soetikno RM, Montes H, et al. Accuracy and complication rates of brush cytology from bile duct versus pancreatic duct. Gastrointest Endosc 1999; 49: 322-7.
122. De Bellis M, Sherman S, Fogel EL, et al. Tissue sampling at ERCP in suspected malignant biliary strictures. Gastrointest Endosc 2002; 56: 720-30.
123. Mansfield JC, Griffin SM, Wadehra V, Matthewson K. A prospective evaluation of cytology from biliary strictures. Gut 1997; 49: 671-7.
124. Kurzawinski T, Deery A, Davidson BR. Diagnostic value of cytology for biliary stricture. Br J Surg 1993; 80: 414-21.
125. Cunningham JT, Lewin D, Tarnasky P, Hoffman B, Hawes R, Cotton PB. A prospective study of multiple sampling methods in the assessment of biliary strictures {abstract}. Gastroentest Endosc 1997; 45: AB128.
126. Stewart CJR, Mills PR, Carter R, et al. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol 2001; 54: 449-55.
127. Rabinowitz M, Zajko AB, Hassanein T, et al. Diagnostic value of brush cytology in the diagnosis of bile duct carcinoma: a study in 65 patients with bile duct strictures. Hepatology 1990; 12: 747-52.
128. Jailwala J, Fogel EL, Shermann S, et al. Triple tissue sampling at ERCP in malignant biliary obstruction. Gastroentest Endosc 2000; 51: 383-90.
129. Lo SK, Cox J, Soltani S. A prospective blinded evaluation of all ERCP sampling methods on biliary strictures {abstract}. Gastroentest Endosc 1996; 43: AB368.
130. Wiersema M, Lehman G, Hawes R, Sherman S, Earle D. Improvement of diagnostic yield of brush cytology in malignant strictures by the use of supplemental tissue sampling technique {abstract}. Gastroentest Endosc 1992; 35: AB265.
131. Slattery JM, Dushyant VS. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist 2006; 11: 912-22 .
132. Han JK, Choi Bi, Kim AY, et al. Cholangiocarcinoma: pictorial essay of CT and Cholangiographic findings. Radiographics 2002; 22: 173-87.
133. Yoon KH, Ha HK, Kim MG, et al. Biliary stricture caused by blunt abdominal trauma: clinical and radiologic features in five patients. Radiology 1998; 207: 737-41.
134. Rosch T, Meining A, Fruhmorgen S, et al. A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures. Gastrointest Endosc 2002; 55: 870-6.
135. Dillon E, Peel ALG, Parkin GJS. The diagnosis of primary bile duct carcinoma (cholangiocarcinoma) in the jaundiced patient. Clin Radiol 1981; 32: 311-7.
136. Itoh S, Ikeda M, Otta T, et al. Assessment of the pancreatic and intrapancreatic bile duct using 0.5-mm collimation and multiplanar reformatted images in multislice CT. Eur Radiol 2003; 13: 277-85.
137. Choi SH, Han JK, Lee JM, et al. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology 2005; 236: 178-83.
138. Feydy A, Vilgrian V, Denys A, et al. Helical CT assessment in hilar cholangiocarcinoma: correlation with surgical and pathologic findings. Am J Roentgenol 1999; 172: 73-7.
139. Lee MG, Lee HJ, Kim MH, et al. Extrahepatic biliary diseases: 3D MR cholangiopancreatography. Radiology 1997; 202: 663-9.
140. Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P. Magnetic resonance imaging of cholangiocarcinoma. Semin Liver Dis 2004; 24: 155-64
141. Ishizaki Y, Wakayama T, Okada Y, et al. Magnetic resonance cholangiography for evaluation of obstructive jaundice. Am J Gastroenterol 1993; 88: 2072-7
142. Becker CD, Grossholz M, Becker M, Mentha G, de Peyer R, Terrier F. Choledocholithiasis and bile duct stenosis: diagnostic accuracy of MR cholangiopancreatography. Radiology 1997; 205: 523-30
143. Vogl TJ, Schwarz WO, Heller M, et al. Staging of klatskin tumors (hilar cholangiocarcinoma): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography. Eur Radiol 2006; 16: 2317-25
144. Zidi SH, Prat F, Le Guen O, Rondeau Y, Pelletier G. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures. Gut 2000; 46: 103-06
145. Fogel EL, Sherman S. How to improve the accuracy of diagnosis of malignant biliary strictures. Endoscopy 1999; 31: 758-60.
146. Magnuson TH, Bender JS, Duncan MD, Ahrendt SA, Harmon JW, Regan F. Utility of magnetic resonance cholangiography in the evaluation of biliary obstruction. J Am Coll Surg 1999; 189: 63-72.
147. Wamsteker EJ. Updates in biliary endoscopy 2006. Curr Opin Gastroenterol 2007; 23: 324-8.
148. Fritscher-Ravens A, Bohuslavizki KH, Broering DC, et al. FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 2001; 22: 1277-85.
149. Anderson CD, Rice MH, Pison CW, Chapman XL, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation gallbladder carcinoma and cholangiocarcinoma. J Gastroentest Surg 2004; 8: 90-7.